198 related articles for article (PubMed ID: 32661101)
1. Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance.
Sur S; Lin Z; Li Y; Yasar S; Rosenberg P; Moghekar A; Hou X; Kalyani R; Hazel K; Pottanat G; Xu C; van Zijl P; Pillai J; Liu P; Albert M; Lu H
Neurology; 2020 Aug; 95(8):e962-e972. PubMed ID: 32661101
[TBL] [Abstract][Full Text] [Related]
2. CO
Sur S; Lin Z; Li Y; Yasar S; Rosenberg PB; Moghekar A; Hou X; Jiang D; Kalyani RR; Hazel K; Pottanat G; Xu C; Pillai JJ; Liu P; Albert M; Lu H
J Cereb Blood Flow Metab; 2024 Mar; ():271678X241240582. PubMed ID: 38489769
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study.
Sleight E; Stringer MS; Clancy U; Arteaga C; Jaime Garcia D; Hewins W; Jochems ACC; Hamilton OKL; Manning C; Morgan AG; Locherty R; Cheng Y; Liu X; Zhang J; Hamilton I; Jardine C; Brown R; Sakka E; Kampaite A; Wiseman S; Valdés-Hernández MC; Chappell FM; Doubal FN; Marshall I; Thrippleton MJ; Wardlaw JM
Stroke; 2023 Nov; 54(11):2776-2784. PubMed ID: 37814956
[TBL] [Abstract][Full Text] [Related]
4. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
[TBL] [Abstract][Full Text] [Related]
5. Slowed Temporal and Parietal Cerebrovascular Response in Patients with Alzheimer's Disease.
Holmes KR; Tang-Wai D; Sam K; McKetton L; Poublanc J; Crawley AP; Sobczyk O; Cohn M; Duffin J; Tartaglia MC; Black SE; Fisher JA; Wasserman B; Mikulis DJ
Can J Neurol Sci; 2020 May; 47(3):366-373. PubMed ID: 32051047
[TBL] [Abstract][Full Text] [Related]
6. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
[TBL] [Abstract][Full Text] [Related]
7. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
[TBL] [Abstract][Full Text] [Related]
8. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
[TBL] [Abstract][Full Text] [Related]
9. Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes.
Brundel M; van den Berg E; Reijmer YD; de Bresser J; Kappelle LJ; Biessels GJ;
J Diabetes Complications; 2012; 26(3):205-9. PubMed ID: 22520398
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular reactivity in Alzheimer's disease signature regions is associated with mild cognitive impairment in adults with hypertension.
Aslanyan V; Mack WJ; Ortega NE; Nasrallah IM; Pajewski NM; Williamson JD; Pa J
Alzheimers Dement; 2024 Mar; 20(3):1784-1796. PubMed ID: 38108158
[TBL] [Abstract][Full Text] [Related]
11. Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults.
Jefferson AL; Cambronero FE; Liu D; Moore EE; Neal JE; Terry JG; Nair S; Pechman KR; Rane S; Davis LT; Gifford KA; Hohman TJ; Bell SP; Wang TJ; Beckman JA; Carr JJ
Circulation; 2018 Oct; 138(18):1951-1962. PubMed ID: 30018169
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
[TBL] [Abstract][Full Text] [Related]
13. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
[TBL] [Abstract][Full Text] [Related]
14. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
15. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
[TBL] [Abstract][Full Text] [Related]
16. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
[TBL] [Abstract][Full Text] [Related]
17. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.
Vemuri P; Wiste HJ; Weigand SD; Shaw LM; Trojanowski JQ; Weiner MW; Knopman DS; Petersen RC; Jack CR;
Neurology; 2009 Jul; 73(4):294-301. PubMed ID: 19636049
[TBL] [Abstract][Full Text] [Related]
18. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Mattsson N; Zetterberg H; Hansson O; Andreasen N; Parnetti L; Jonsson M; Herukka SK; van der Flier WM; Blankenstein MA; Ewers M; Rich K; Kaiser E; Verbeek M; Tsolaki M; Mulugeta E; Rosén E; Aarsland D; Visser PJ; Schröder J; Marcusson J; de Leon M; Hampel H; Scheltens P; Pirttilä T; Wallin A; Jönhagen ME; Minthon L; Winblad B; Blennow K
JAMA; 2009 Jul; 302(4):385-93. PubMed ID: 19622817
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
20. Lower Cerebrovascular Reactivity Contributed to White Matter Hyperintensity-Related Cognitive Impairment: A Resting-State Functional MRI Study.
Ni L; Zhang B; Yang D; Qin R; Xu H; Ma J; Shao P; Xu Y
J Magn Reson Imaging; 2021 Mar; 53(3):703-711. PubMed ID: 32996183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
